The safest weight loss device option that doesn’t alter your patients’ anatomy and allows your patients to eat a normal variety of foods.

A completely different approach to obesity

An entirely new approach to obesity, vBloc® Therapy is the only neurometabolic therapy FDA approved to treat obesity.

  • Leverages trusted and proven neuromodulation technology to block the hunger signals that travel along the vagus nerve, between the stomach and the brain
  • vBloc Therapy has been studied in over 650 patients worldwide through multiple clinical trials published in peer-reviewed journals
    • The longest patient implanted is over 8 years on therapy
    • Multiple studies have shown durable weight loss and improvement in a variety of co-morbid conditions

Experience vBloc

Eligible Patients

Patients may be candidates for vBloc Therapy if they meet the following criteria:

  • Have tried to lose weight by diet and exercise in a supervised program within the last 5 years

  • Are at least 18 years of age

  • Have a BMI of 35 to 39.9 with a health-related condition such as: type 2 diabetes, high blood pressure, sleep apnea, high cholesterol




    BMI of 40 to 45

treatment of care continuum

Treatment Care Continuum

With so many patients opting to avoid obesity treatment, it’s obvious there’s a gap between patient need and a practical solution. vBloc Therapy addresses it. It is estimated that over 14 million people in the US are eligible for vBloc Therapy. 2

Clinically significant weight loss

In the FDA trial, patients who used vBloc Therapy as directed for 12 hours per day achieved an average EWL of 28% at 12 months and achieved clinically significant health benefits..3


Clinical outcomes

85% of vBloc patients in a feasibility study were able to maintain, decrease or discontinue their diabetes medications while achieving improved glycemic control at 12 months..4


The safest implanted device for obesity. 1.9% device related serious adverse event rate through 12 months.

Short recovery times

Majority of vBloc patients can be treated in an outpatient setting.6

Minimally invasive and non-anatomy altering

Minimally invasive and non-anatomy altering to give patients a non-restrictive option.

Device and MoA

See the technology behind vBloc Therapy and how it works to control hunger.

vBloc Physician Sign Up

Sign up for a complete repository of resources, full clinical data, and videos to help you grow your practice with vBloc Therapy.

Sign Up

Would you like to take the next step in learning more about this revolutionary technology and how you can offer it to your patients? Fill out the contact form, and we’ll call you right away!

Sign Up